Compare Mirena and Implanon costs over the same period
The first quoted price is usually what you pay on the day a device is placed.
A smaller initial payment does not necessarily mean a smaller cost over several years.
Replacement devices, insertion procedures, removal of the previous device and follow-up visits can add to the budget.
This calculator compares Korean provider quotes for Mirena, Kyleena, Jaydess, a copper IUD, Implanon NXT and an oral contraceptive over one common planning period.
It shows gross cost, net cost after confirmed reimbursement, annualized cost and monthly average cost, alongside the initial payment you need to prepare.
Use the comparison after checking medical suitability
The figures are budgets for options your clinician considers appropriate.
Bleeding patterns, uterine conditions, current medicines and the reason for treatment can change which options are suitable.
A price difference does not establish a difference in clinical quality.
When planning treatment for heavy menstrual bleeding or dysmenorrhea, do not assume that another device provides the same therapeutic effect as Mirena.
Confirm suitable options in consultation and include only those options in your comparison.
Device periods and replacement planning
Mirena: contraception 8 years, therapy 5 years
The Korean MFDS product information specifies 8 years for contraception and 5 years for heavy menstrual bleeding, dysmenorrhea and local progestin use during estrogen replacement therapy.
The default planning interval is 60 months even for contraception; you may change it to a confirmed plan of up to 96 months.
For a therapeutic purpose, a single-device interval above 60 months is held for correction.
Kyleena, Jaydess and Implanon NXT
The domestic sources checked specify 5 years for Kyleena, 3 years for Jaydess and 3 years for Implanon NXT.
A period approved for a similarly named overseas product is not applied to the Korean product.
A 36-month device cannot cover a 60-month plan without a second placement, so the calculation includes that placement and removal of the first device.
Copper IUD
The duration depends on the specific copper IUD.
The displayed 60-month input is a provisional plan, not an approved duration for every copper device.
Confirm the product and its replacement deadline with the provider, then select the product-period confirmation checkbox.
Do not extend use by borrowing a duration from a different device.
Oral contraceptive
The model multiplies the monthly patient medicine quote by the number of months, then adds a one-time initial additional cost and the follow-up budget.
Device placement and removal counts do not apply.
A pack may not correspond exactly to a calendar month; convert the actual prescription or pharmacy quote to a monthly budget.
The calculator does not select the medicine or its dosing schedule.
Korean NHI: covered Mirena, full drug payment and non-covered care
HIRA distinguishes therapeutic levonorgestrel use from contraceptive use.
Notice 2013-127, effective September 1, 2013, is documented in the official drug criteria compilation.
Selecting a therapeutic purpose or reporting menstrual pain does not by itself establish eligibility.
Ask the clinician and billing office whether the relevant conditions and billing classification apply.
- Confirmed heavy menstrual bleeding.
- Dysmenorrhea that prevents daily activities for 1–2 days per menstrual cycle.
- Estrogen replacement therapy where a progestin cannot be used or metabolic function, such as liver function, is problematic.
Full therapeutic drug payment differs from non-covered contraception
When therapeutic use is within the approved indication but outside the recognition criteria, the patient pays the full drug cost.
The drug is non-covered when used for contraception.
The calculator therefore provides a separate full-drug-payment formula instead of merging these categories.
Even in that formula, the procedure must be separately confirmed as covered before applying a copay rate to its covered total.
Use a direct patient quote when the billing basis remains uncertain.
Direct quotes carry the provider-reported classification: covered patient payment, full patient payment, non-covered, mixed or unconfirmed.
A confirmed patient amount can be compared financially even when its billing classification is still unknown.
In covered Mirena mode, confirming a comparable non-covered quote also enables the whole-period medical-cost saving before insurance.
Removal, follow-up and additional charges are assumed identical; a negative value means no saving.
HIRA guidance treats patient-requested contraceptive IUD insertion, R4271, as non-covered while identifying health-related exceptions.
The calculator does not declare every purpose and every device non-covered.
Korean National Health Insurance and private indemnity insurance are separate systems; NHI coverage alone does not confirm a private reimbursement.
Input meanings and avoiding duplicate charges
Device and placement patient quote
In the direct-quote mode, enter the amount the patient actually pays.
Do not confuse it with the total bill before NHI pays its share.
A copay percentage is not applied again to an already quoted patient amount.
If the device and insertion are bundled, do not add the same insertion charge again as an additional cost.
Drug ceiling and covered procedure total
The Mirena ceiling for drug code 641100600 is KRW 159,824 per set, effective January 1, 2026.
This is not a fixed non-covered procedure price.
Formula modes separate the drug amount from the covered procedure total and apply a provider-confirmed copay rate.
The 30% input is an arithmetic assumption, not a rate for every Korean visit.
Additional costs, removal and follow-up
Enter a per-placement additional charge if tests or separate visits recur with each placement.
The removal quote is multiplied by replacement removals plus an optional final removal.
Enter zero for an additional item already included in a package.
Annual follow-up costs are spread proportionately over the planning months, including partial years.
Quote and insurance confirmation
Results remain pending until the quote is confirmed, so an unknown amount is not presented as free care.
Insurance is a confirmed total for the entire comparison period and is subtracted only when its confirmation checkbox is selected.
The same payment is not automatically repeated at every replacement.
Confirm exclusions, deductibles and limits with your insurer.
Gross cost and annualized cost formulas
Count whole replacements
Let H be the comparison months and L the replacement interval in months.
Placements = ceil(H/L); replacements = placements − 1.
Removals = replacements + the optional final-removal flag.
A plan ending exactly at 36 months does not buy another 36-month device.
A 37-month plan pays the full second-device cost upfront.
The last device has no assumed refund or residual value for its unused period.
Patient cost and confirmed reimbursement
Device gross cost = placement patient cost × placements + removal quote × removals + annual follow-up budget × H/12.
Covered Mirena placement cost = round(drug price × copay rate/100) + round(covered procedure total × copay rate/100) + additional placement cost.
Full-drug mode adds the entire drug price to the separately covered procedure patient amount and additional cost.
Insurance deduction = min(gross cost, confirmed whole-period reimbursement).
Net cost = gross cost − insurance deduction; annualized = net cost × 12/H; monthly average = net cost/H.
Displayed amounts are rounded to whole KRW.
Rounding is an arithmetic planning convention.
It does not reproduce every statutory billing adjustment, separate consultation charge or provider-specific exception.
Article 19 and Annex 2 of the National Health Insurance Act Enforcement Decree provide the copay framework; this model uses the rate confirmed for your bill.
The initial payment differs from a multi-year monthly average, so check both before preparing funds.
Step-by-step use
- Confirm the clinically appropriate options and purpose, then enter your actual intended months of use.
If pregnancy planning means removal after one year, use 12 months rather than the maximum approved duration.
- Ask which device, placement, anesthesia, testing, consultation, removal and follow-up items are included.
Separate packages from extras and avoid charging for the same item twice.
- Use a Mirena formula only after the provider confirms drug billing, procedure coverage and the copay rate.
Otherwise obtain a direct patient quote or leave the result pending.
- Set the replacement interval, final removal and annual follow-up budget.
Copper IUD calculations require confirmation of the particular product period.
- Subtract only confirmed insurance for the entire period and review initial payment, gross cost, net cost and annual or monthly averages.
Do not compare a pending row as if it were a zero-cost option.
- Enter a start date and your follow-up plan, then save assumptions and results as TXT or print them.
Confirm appointments and submit any insurance claim separately through the provider and insurer.
Worked examples using fictional quotes
These figures explain the arithmetic; they are not market averages or real provider quotes.
The common period is 60 months, with no final removal, additional costs, follow-up or insurance deduction.
Implanon is assumed to cost KRW 300,000 per placement, with KRW 30,000 for a replacement removal; oral medicine is KRW 15,000 per month.
Placements, gross and annualized costs under fictional 60-month assumptions| Method and assumption | Placements | Gross cost | Annualized |
|---|
| Mirena KRW 400,000 / 60 months | 1 | KRW 400,000 | KRW 80,000 |
| Implanon KRW 300,000 / 36 months | 2 | KRW 630,000 | KRW 126,000 |
| Oral medicine KRW 15,000/month | 0 | KRW 900,000 | KRW 180,000 |
Covered drug versus full drug payment
Assume a KRW 159,824 drug, a KRW 50,000 covered procedure total and a confirmed 30% rate.
The rounded drug patient cost is KRW 47,947; the procedure patient cost is KRW 15,000.
Their sum is KRW 62,947 per placement, annualized to KRW 12,589 over 60 months.
Full-drug payment is KRW 159,824 + KRW 15,000 = KRW 174,824.
Only under these assumptions, a KRW 400,000 non-covered quote differs from KRW 62,947 by KRW 337,053.
Different billing conditions invalidate that assumed saving.
A KRW 400,000 device used for a contraceptive plan of 96 months, with no extras, annualizes to KRW 50,000.
If the same device is removed after 12 months, annualized cost is KRW 400,000 before any removal charge.
The intended period can substantially change the comparison even when the initial quote is identical.
Read the replacement, removal and follow-up schedule
A start date produces calendar dates for initial placement, planned replacements, optional final removal and your follow-up schedule.
Without a start date, the schedule uses relative months such as 0 or 36.
January 31, 2026 plus one month becomes February 28, 2026.
Every date is calculated from the original start date, preventing a short intermediate month from repeatedly pulling later dates earlier.
Clinical intervals and budget allocation are separate
A follow-up interval of zero means no schedule has been entered; it does not mean follow-up is unnecessary.
Enter the plan discussed with your clinician.
The annual follow-up budget is allocated proportionately across the months, so adding a schedule event does not automatically add a charge.
Check actual visits and the annual total together.
Confirm removal timing, replacement timing and continued contraception in consultation.
Practical scenarios and interpreting results
Planning several years
A KRW 400,000 initial payment and monthly medicine purchases have different cash timing.
First check whether the initial payment is available, then compare total costs over the same period.
A low monthly average does not mean that this amount alone pays for placement.
Stopping early for pregnancy planning
Shorten the comparison period if planned removal is earlier than the product maximum.
Include final removal to budget for early stopping.
No refund for unused device life is assumed; ask the billing office separately if a refund agreement exists.
Checking therapeutic billing
Compare covered Mirena drug payment with full drug payment to prepare questions for consultation.
Do not enter an unconfirmed diagnosis or severity merely to obtain a covered estimate.
Testing, consultations and procedures may have their own billing classifications.
Receiving insurance later
Gross cost represents the medical budget before reimbursement; net cost represents cost after the confirmed payment.
Initial payment may be required before an insurer pays.
A negative Mirena minus Implanon difference means lower Mirena net cost under the entered assumptions, without establishing a medical recommendation.
Cautions and limits
- The model plans normal use without estimating the probability of expulsion, adverse effects, unexpected testing or re-intervention.
Update the period and extra charges when a new quote is available.
- Prices remain at the entered nominal amounts throughout the comparison.
Future drug or procedure price changes, discounts, inflation, investment returns and discount rates are excluded.
- A drug ceiling, a procedure code and a product duration come from different sources.
A code alone does not determine an individual benefit decision or final procedure fee.
- Private policy-generation reimbursement formulas, NHI copay ceiling refunds, medical-expense tax credits and local subsidies are not calculated.
Only the confirmed whole-period insurance amount is deducted once, capped at gross medical cost.
- The latest Enforcement Decree text marks an Annex 2 amendment for January 1, 2027.
That future annex is not automatically applied to 2026 planning; enter the provider-confirmed rate.
- Calculation runs in your browser without sending purpose, amounts or dates to a server or analytics event properties.
The downloaded TXT includes the selected purpose and assumptions; inspect it before sharing.
Frequently asked questions
Does menstrual pain always make Mirena covered?
No.
The clinician must confirm diagnosis, symptom severity or the estrogen-therapy conditions.
Approved therapeutic use can still require full drug payment when recognition criteria are not met.
Confirm the billing classification with the provider.
Is KRW 159,824 the complete placement price?
It is the NHI ceiling per drug set.
Procedure, visits and testing are separate, and it is not a fixed non-covered selling price.
Use direct-quote mode when you have an actual patient package quote.
Does Implanon cost KRW 100,000 a year in a five-year plan?
With KRW 300,000 per placement and a 36-month interval, a 60-month plan requires two placements.
One KRW 30,000 removal makes gross cost KRW 630,000 and annualized cost KRW 126,000.
Dividing only by one device lifespan misses the second upfront payment.
Is another device placed exactly at the end of its interval?
No new device is bought when the comparison ends at that point.
A 36-month plan has no replacement, while a 37-month plan needs another device.
Final removal is included only if selected.
Are other devices and oral medicines always non-covered for therapy?
The calculator does not determine every therapeutic indication or billing classification.
Enter the provider-confirmed patient amount and confirm whether that option is clinically appropriate for your treatment.
Is insurance automatically repeated at every replacement?
Only the confirmed reimbursement total for the whole comparison is subtracted once.
Without confirmation, the deduction is zero; excessive reimbursement is capped at gross cost.
Initial payment before reimbursement is unchanged.
Why is an unconfirmed quote pending?
Unknown items should not be treated as free care.
Confirm included items and whether extra, removal and follow-up charges are zero, then select quote confirmation.
Numeric edits are committed when focus leaves the field.
Can I treat the schedule as confirmed appointments?
It is a planning reference.
Confirm clinical removal deadlines and follow-up intervals with the clinician and book appointments separately.
You can also save relative months without a start date for discussion.
Official sources, verification and consultation preparation
Sources were checked on October 5, 2026 for Korean 2026 planning.
The evidence combines Medical Care Benefit Rules Article 5, Enforcement Decree Article 19 and Annex 2, and HIRA drug and procedure guidance.
The official API returned Rules MST285513, Decree MST289701 and drug-notice serial2100000285598.
Notice2026-192 is effective October 1, 2026; its amendment attachment does not itself return the complete Mirena criteria, so the official HIRA compilation is also used.
No unverified product-label amendment date or future price is invented.
Complete the comparison with an itemized quote
Ask whether each method is suitable for your purpose, how the Mirena drug and procedure are billed, and what testing, removal, replacement and follow-up cost.
Before placement, recheck the price effective date, recognition criteria, domestic product period and private insurance scope.
Enter the confirmed figures and actual intended period above, then save the comparison with its assumptions to identify missing items during consultation.